-
Group
BackGroupView
-
Who we are
BackWho we areView
- Profile
- Key figures
-
Governance
BackGovernanceView
-
Governance
- Quick Access
- Executive Committee
- 2019 Annual Report
- Air Liquide Foundation website
- Our history
-
Who we are
- Quick Access
- Executive Committee
- 2019 Annual Report
- Air Liquide Foundation website
-
What we do
BackWhat we doView
- At a glance
- Large Industries
- Industrial Merchant
- Healthcare
- Electronics
- Engineering & Construction
- Global Markets & Technologies
-
What we do
- Quick Access
- Executive Committee
- 2019 Annual Report
- Air Liquide Foundation website
-
Our strategy
BackOur strategyView
-
Our strategy
- Quick Access
- Executive Committee
- 2019 Annual Report
- Air Liquide Foundation website
-
Innovation
BackInnovationView
-
Research & Development
BackResearch & DevelopmentView
-
Research & Development
- Quick Access
- Executive Committee
- 2019 Annual Report
- Air Liquide Foundation website
- Digital transformation
-
Global markets & Technologies
BackGlobal markets & TechnologiesView
-
Global markets & Technologies
- Quick Access
- Executive Committee
- 2019 Annual Report
- Air Liquide Foundation website
- Air Liquide Venture Capital
-
Innovation
- Quick Access
- Executive Committee
- 2019 Annual Report
- Air Liquide Foundation website
-
Research & Development
-
Sustainable development
BackSustainable developmentView
- Safety
-
Ethics
BackEthicsView
-
Ethics
- Quick Access
- Executive Committee
- 2019 Annual Report
- Air Liquide Foundation website
- Human rights
- Climate objectives
- Environmental data
- Vigilance plan
- Extra-financial ratings
-
Stakeholders
BackStakeholdersView
-
Stakeholders
- Quick Access
- Executive Committee
- 2019 Annual Report
- Air Liquide Foundation website
-
Sustainable development
- Quick Access
- Executive Committee
- 2019 Annual Report
- Air Liquide Foundation website
- Where we operate
- Group publications
-
Group
- Quick Access
- Executive Committee
- 2019 Annual Report
- Air Liquide Foundation website
-
Who we are
-
Businesses
BackBusinessesView
-
Industry
BackIndustryView
-
Industry
-
Healthcare
BackHealthcareView
- Presentation
-
Our expertise
-
Our R&D
- Diseases
-
Public health challenges
BackPublic health challengesView
- Aging population
- Rise in chronic diseases
- Urbanization and lifestyle changes
- Reinventing the hospital
-
Public health challenges
-
Healthcare
-
Electronics
-
Engineering & Construction
BackEngineering & ConstructionView
-
Engineering & Construction
-
Science & New energies
BackScience & New energiesView
-
Science & New energies
-
Businesses
-
Industry
-
Magazine
BackMagazineView
- Industry of the future
- Healthcare
- Energy transition
- Customer experience
- Digitization
- Open innovation
- Science
-
Magazine
- Customers
-
Shareholders
BackShareholdersView
- Stock & Share: shareholders' mag
- Become a shareholder
-
Follow the Air Liquide share
BackFollow the Air Liquide shareView
-
Follow the Air Liquide share
- Access your Account
- Open a share Account
- Quick Access
- 2020 Annual General Meeting
- Forms
- Contact us
-
Factsheets
BackFactsheetsView
- Understanding the stock market
- Stock orders
- Shareholding options
- Registering shares
- Loyalty bonus
- Personal online Account
- Capital gains
- Free share attribution
- Dividend
- Taxation
- Passing on shares
-
Factsheets
- Access your Account
- Open a share Account
- Quick Access
- 2020 Annual General Meeting
- Forms
- Contact us
- Shareholders' Communication Committee
- Annual General Meeting
- Agenda
-
Media library
BackMedia libraryView
-
Media library
- Access your Account
- Open a share Account
- Quick Access
- 2020 Annual General Meeting
- Forms
- Contact us
- Contact us
-
Shareholders
- Access your Account
- Open a share Account
- Quick Access
- 2020 Annual General Meeting
- Forms
- Contact us
-
Investors
BackInvestorsView
- Agenda
- Documents & Presentations
- Vara consensus
-
Investing in Air Liquide
BackInvesting in Air LiquideView
-
Investing in Air Liquide
- Quick Access
- First Half 2020 Results
- 2019 Universal Registration Document
- Group's latest press releases
-
Credit investor
BackCredit investorView
-
Credit investor
- Quick Access
- First Half 2020 Results
- 2019 Universal Registration Document
- Group's latest press releases
-
Governance
BackGovernanceView
- Corporate officers remuneration and regulated commitments
- Board committees
- Capital and articles of association, Internal Regulations, disclosure of share buy-back transactions
-
Governance
- Quick Access
- First Half 2020 Results
- 2019 Universal Registration Document
- Group's latest press releases
- Regulated information
- Contact us
-
Investors
- Quick Access
- First Half 2020 Results
- 2019 Universal Registration Document
- Group's latest press releases
-
Media
-
Careers
BackCareersView
- Job offers
- I choose Air Liquide
-
Careers at Air Liquide
BackCareers at Air LiquideView
-
Careers at Air Liquide
- Find our job offers
- Spontaneous application
-
You at Air Liquide
BackYou at Air LiquideView
-
You at Air Liquide
- Find our job offers
- Spontaneous application
- Students
-
Graduates
BackGraduatesView
-
Graduates
- Find our job offers
- Spontaneous application
Healthcare: Air Liquide builds new specialty ingredients production facility in the U.S. for the cosmetic and pharmaceutical markets
Air Liquide announces that its subsidiaries Seppic, healthcare specialty ingredients manufacturer, and Schülke, hygiene specialist, broke ground on a green-field state of the art production facility in Sandston, Henrico County - Virginia, United States. Expected to start operations in the first half of 2018, the planned investment is over $60 million1 and will create approximately 50 new jobs in the community.
This new production facility will manufacture ingredients for the cutting-edge cosmetic and pharmaceutical global markets. The market for personal care specialty ingredients is worth more than $10 billion globally, of which the U.S. represents 25%.
With this facility, the two companies will strengthen their proximity to American customers. The facility is located in the Northeast of the U.S., where the majority of the companies’ customers are. It will be run by a joint venture between Seppic and Schülke, named Polykon Manufacturing. Their resulting synergies will enable to create additional value in their field of expertise while addressing the growing need for innovations in these markets.
François Jackow, member of the Air Liquide group’s Executive Committee, supervising the Healthcare activities, said: “Seppic and Schülke have a long presence in the United States serving leading health and beauty care customers. This first manufacturing unit for the two companies in the U.S. will extend their innovative potential and enlarge their industrial footprint and proximity with customers within North America, while strengthening their manufacturing capabilities globally. With this investment, Air Liquide pursues the development of its Hygiene and Specialty Ingredients activities, thus strengthening the Group’s Healthcare business in this region.”
1 A 2015 investment decision
Air Liquide Healthcare
supplies medical gases, home healthcare services, hygiene products, medical equipment and specialty ingredients. In 2015, it served over 7,500 hospitals and 1.3 million patients at home throughout the world. The Group’s Healthcare business reached €2,800 million in revenues in 2015, with the support of its 13,500 employees.
Seppic in brief
Subsidiary of the Air Liquide group within the Healthcare activity, Seppic designs and supplies a wide range of specialty ingredients for health and beauty care. Present in over 100 countries through its affiliates and network of distributors, Seppic employs 630 people around the world, including 100 employees dedicated to innovation. www.seppic.com
Schülke in brief
Subsidiary of the Air Liquide group within the Healthcare activity and expert in hospital disinfection, Schülke designs and supplies since more than 125 years a wide range of disinfectants and antiseptics mainly for medical environment to actively contribute to patient safety. Present in 80 countries through its affiliates and network of distributors, Schülke employs over 900 people around the world, including 70 researchers. www.schuelke.com
supplies medical gases, home healthcare services, hygiene products, medical equipment and specialty ingredients. In 2015, it served over 7,500 hospitals and 1.3 million patients at home throughout the world. The Group’s Healthcare business reached €2,800 million in revenues in 2015, with the support of its 13,500 employees.
Subsidiary of the Air Liquide group within the Healthcare activity, Seppic designs and supplies a wide range of specialty ingredients for health and beauty care. Present in over 100 countries through its affiliates and network of distributors, Seppic employs 630 people around the world, including 100 employees dedicated to innovation. www.seppic.com
Subsidiary of the Air Liquide group within the Healthcare activity and expert in hospital disinfection, Schülke designs and supplies since more than 125 years a wide range of disinfectants and antiseptics mainly for medical environment to actively contribute to patient safety. Present in 80 countries through its affiliates and network of distributors, Schülke employs over 900 people around the world, including 70 researchers. www.schuelke.com
Download the pdf
© Air Liquide 2019